Unlocking potential:
How AI is shaping the drug development pipeline

Join Charlotte Guzzo and experts Parker Moss, Margo Georgiadis, and Guillermo de Angel in a one-hour webinar exploring AI's impact on drug development. This discussion will cover AI's significant contributions to the field, the relationship between data growth and algorithmic innovation, and AI utilisation in large pharma versus biotech. The session aims to provide practical insights into how various organisations leverage AI for drug discovery and development efficiencies, and what that means for the future of healthcare.

 

Thumbnail Image

Thank you, click to play

Unlock webinar: Enter your details

 

Our panel of experts

 

Group 48095544

Charlotte Guzzo

COO & Co-Founder
Sano Genetics

Linkedin
noun-globe-5360693-F75338
Group 48095541

Parker Moss

Executive Vice President of
Corporate Development Exscientia

Linkedin
noun-globe-5360693-F75338
Group 48095543

Margo Georgiadis

CEO & Co-Founder
Montai Health

Linkedin
noun-globe-5360693-F75338
Group 48095542

Guillermo Del Angel

Executive Director, Center for Genomics Research
AstraZeneca

Linkedin
noun-globe-5360693-F75338